Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Flexion Therapeutics submits NDA to FDA for Zilretta

Dec. 13, 2016

New U.K. alliance established to accelerate development of treatments for arthritis

Dec. 12, 2016

Novel drug targets described at the ACR/ARHP annual meeting

Dec. 9, 2016

Takeda describes new Toll-like receptor 4 antagonists

Dec. 7, 2016

Scientists identify methylated regions associated with hand osteoarthritis

Dec. 5, 2016

Biophytis' Sarconeos safe in SARA-PK clinical study

Dec. 2, 2016

IL-1 blockade with anakinra evaluated for CPPD crystal arthritis

Nov. 30, 2016

Phase III rheumatoid arthritis study finds equivalence between rituximab and biosimilar CT-P10

Nov. 28, 2016

Shionogi signs license agreement with Tokushima University for novel type A2 Botulinum toxin

Nov. 25, 2016

Novel dexamethasone prodrug ZSJ-0228 has lower systemic exposure, improved safety

Nov. 25, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...